Abstract | STUDY OBJECTIVE: To describe the perioperative blood conservation strategies and postoperative outcomes in patients who undergo complex spinal surgery for tumor resection and who also refuse blood product transfusion. DESIGN: A retrospective case series. SETTING: A single-center, tertiary care and academic teaching hospital in Canada. PATIENTS: All adult patients undergoing elective major spine tumor resection and refusing blood product transfusion who were referred to our institutional Blood Utilization Program between June 1, 2004, and May 9, 2014. MEASUREMENTS: MAIN RESULTS: CONCLUSIONS: Patients who decline blood product transfusion can successfully undergo major spine tumor resection. Careful patient selection and timely referral for perioperative optimization such that the risk of severe anemia is minimized are important for success.
|
Authors | Alexandra E Kisilevsky, Liam Stobart, Kristine Roland, Alana M Flexman |
Journal | Journal of clinical anesthesia
(J Clin Anesth)
Vol. 35
Pg. 434-440
(Dec 2016)
ISSN: 1873-4529 [Electronic] United States |
PMID | 27871571
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
- Antifibrinolytic Agents
- Erythropoietin
- Iron
|
Topics |
- Adult
- Antifibrinolytic Agents
(therapeutic use)
- Blood Transfusion, Autologous
(methods)
- Erythropoietin
(therapeutic use)
- Female
- Hemodilution
(methods)
- Humans
- Intraoperative Care
(methods)
- Iron
(therapeutic use)
- Jehovah's Witnesses
- Male
- Middle Aged
- Postoperative Complications
(prevention & control)
- Preoperative Care
(methods)
- Retrospective Studies
- Spinal Neoplasms
(surgery)
|